Dermatologists' interest in Stelara [ustekinumab] is high, according to a survey carried out by the BioTrends Research Group

Author unknown

Open source

DOI: 10.2165/00151234-200905930-00024
Published: 2009-12
Container: PharmacoEconomics & Outcomes News
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2165/00151234-200905930-00024,
  title = {Dermatologists' interest in Stelara [ustekinumab] is high, according to a survey carried out by the BioTrends Research Group},
  year = {2009},
  journal = {PharmacoEconomics \&amp; Outcomes News},
  doi = {10.2165/00151234-200905930-00024},
  url = {https://doi.org/10.2165/00151234-200905930-00024}
}

RIS

TY  - JOUR
TI  - Dermatologists' interest in Stelara [ustekinumab] is high, according to a survey carried out by the BioTrends Research Group
PY  - 2009
JO  - PharmacoEconomics &amp; Outcomes News
DO  - 10.2165/00151234-200905930-00024
UR  - https://doi.org/10.2165/00151234-200905930-00024
ER  -

APA

Dermatologists' interest in Stelara [ustekinumab] is high, according to a survey carried out by the BioTrends Research Group. (2009). PharmacoEconomics & Outcomes News. https://doi.org/10.2165/00151234-200905930-00024

Source records

crossref · retrieved 2026-09-26T04:54:56.592Z